Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...
Bird flu isn’t part of the “quad-demic” of viruses circulating through the country this winter—COVID, seasonal flu, ...
The government is working to head off human bird flu infections. The U.S. government has awarded Moderna $590 million to ...
The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.
The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...
Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...
The Department of Health and Human Services has granted millions of dollars to Moderna to speed up bird flu vaccine development.
In 2023, Moderna initiated a study on a “pandemic influenza vaccine” to protect against H5 and H7 avian influenza viruses. In July, the company received $176 million from HHS toward its ...
The funding, which follows the $176 million the government awarded Moderna in June 2024, aims to get mRNA vaccines ready ...
The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of ...
To that end, HHS has granted Moderna $590 million to help accelerate the development of a bird flu vaccine. The agency announced its backing of the Massachusetts-based pharmaceutical firm about 72 ...